share_log

KalVista Pharmaceuticals Q1 EPS $(0.94) Down From $(0.66) YoY

Benzinga Real-time News ·  Sep 8, 2022 07:11

KalVista Pharmaceuticals (NASDAQ:KALV) reported quarterly losses of $(0.94) per share. This is a 42.42 percent decrease over losses of $(0.66) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment